Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiodermatitis 1 Fibrosis 1

Interventions

pembrolizumab 602 Cyclophosphamide 545 Magnetic Resonance Spectroscopy 524 Radiotherapy 513 Specimen Handling 506 Nivolumab 412 Cisplatin 380 Carboplatin 368 Biopsy 306 Blood Specimen Collection 302 Radiosurgery 290 Paclitaxel 280 Surveys and Questionnaires 270 Gemcitabine 270 Standard of Care 267 Drug Therapy 263 Dexamethasone 263 fludarabine 262 Bevacizumab 253 venetoclax 251 Oxaliplatin 209 Capecitabine 201 Rituximab 198 Radiation 192 Fluorouracil 189 Ipilimumab 188 durvalumab 184 Doxorubicin 179 Etoposide 176 atezolizumab 175

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Catechin × 1 year × Clear all

NCT07149506 2025-09-08

OCTOPUS-RD

Universidad de Guanajuato

Phase 3 Enrolling by invitation

Fibrosis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡